Chronic Kidney Disease is a global health problem that is rapidly increasing and becoming a worldwide health burden. The number of patients with End-Stage Kidney Disease (ESKD) is continuously rising globally. In 2010, there were 2.6 million ESKD patients receiving Kidney Replacement Therapy (KRT), and this number is projected to increase to 5.4 million by 2030. It is estimated that 2.2 to 7 million people with End-Stage Kidney Disease worldwide die due to not receiving kidney replacement therapy

Based on reports from the Indonesia Renal Registry, the number of patients with End-Stage Kidney Disease in Indonesia continues to increase year by year. The growing number of patients with kidney disease presents increasingly significant challenges and problems that need to be addressed. Widespread self-screening in at-risk patient populations needs to be pursued. Efforts to prevent the progression of kidney disease must be carried out comprehensively and continuously. Various innovations and applications of the latest scientific knowledge are needed to improve the quality of healthcare services and medical science in the field of nephrology and hypertension.

Various modalities of Kidney Replacement Therapy must be provided for patients with end-stage kidney disease. The availability and accessibility of high-quality kidney replacement therapy services need to be jointly pursued. The development and refinement of existing dialysis techniques must be disseminated to improve patient survival and quality of life.

PERNEFRI carries out its mandate to continuously innovate and advance scientific knowledge and the development of healthcare services in the field of nephrology and hypertension. The Working Conference (KONKER) and Annual Meeting of PERNEFRI are routine PERNEFRI activities aimed at providing information on the advancements in medical science, particularly in nephrology and hypertension, to both general practitioners and specialist doctors.